Showing 41 - 60 results of 569 for search '"USA"', query time: 0.05s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56

    Resource availability and competition shape pollinator trophic specialization in longleaf pine savannas by Pablo Moreno-García, Johanna E. Freeman, Benjamin Baiser, Joshua W. Campbell, Daijiang Li

    Published 2025-03-01
    “…We used samples collected over an entire flowering season in 24 xeric pine savannas in north-central Florida, USA and evaluated the effects of plant availability and pollinator competitor pool on three aspects of trophic specialization: taxonomic specialization (pollinator selection of plant species), phylogenetic specialization (pollinator selection of plant phylogenetic lineages), and functional specialization (pollinator selection of plant functional traits). …”
    Get full text
    Article
  17. 57
  18. 58
  19. 59
  20. 60

    Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States by Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO

    Published 2025-02-01
    “…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email [email protected]: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
    Get full text
    Article